top of page

National Institute for Health and Care Excellence (NICE) Conference 2026

  • Writer: IWBCA
    IWBCA
  • Oct 17, 2025
  • 3 min read

The National Institute for Health and Care Excellence (NICE) will convene the NICE Conference 2026, a one-day national forum bringing together policymakers, clinicians, commissioners, patient representatives, and industry leaders. The event arrives at a pivotal moment for the UK health and care system, which faces simultaneous pressures of rising demand, constrained budgets, and rapid technological advancement. The conference provides a platform to examine how evidence-based policy, clinical innovation, and financial sustainability can align to support equitable care delivery.


Recent analyses underscore the urgency of these conversations. The NHS Long Term Plan projects that service demand will continue to outpace workforce growth without strategic adoption of technology and prevention-focused care. Studies published in The Lancet and BMJ highlight that digital transformation and early intervention are among the most cost-effective strategies for improving population health outcomes. Against this backdrop, NICE’s role in evaluating and approving health technologies while safeguarding cost-effectiveness has never been more critical.


This year’s conference will focus on how NICE is guiding the NHS through a period of accelerated digital innovation and the introduction of new preventative interventions. The agenda will address the practical challenge of ensuring that rapid scientific progress benefits patients without compromising the financial integrity of the health system. Expert panels will examine how NICE’s evidence-based guidance informs real-world clinical practice and continues to shape outcomes across both primary and specialist care.





Highlights



Over the course of twelve hours of discussion and debate, speakers from across the health and care sector will address:


  • NICE’s collaboration with the NHS, government departments, and international health agencies in advancing the UK’s ten-year health plan.


  • Development of targeted guidance in areas of unmet need, particularly where disparities in access and outcomes persist.


  • The ethical and economic challenges of determining value in a system facing ongoing fiscal pressure.


  • Re-evaluation of legacy technologies to ensure that historic approvals continue to deliver clinical and economic benefit.


  • NICE’s contribution to global health governance through evidence exchange and participation in international policy frameworks.


The NICE Conference 2026 will serve as both a barometer and a blueprint for the future of evidence-based healthcare, defining how innovation, equity, and accountability can coexist within a modern, publicly funded system.





Registration and Attendance



Registration for the NICE Conference 2026 is now open. Delegate rates are structured by sector to ensure access across public, private, and third-sector organisations, with preferential pricing available for early registrants until 15 September 2025. Standard rates will apply from 16 September 2025 through 17 March 2026. Interested participants may secure attendance or request an invoice by visiting niceconference.co.uk, emailing NICE@dods-events.com, or calling +44 (0)207 593 5669.


The conference is designed for professionals involved in health and social care policy, service delivery, research, and innovation. Attendance provides direct engagement with NICE leadership and key partners responsible for shaping the future of healthcare standards and funding decisions.





Why This Event Matters



The NICE Conference is a cornerstone event in the UK health policy calendar. It functions as a national forum for accountability, where evidence-based decision-making, public spending, and patient outcomes intersect. As independent evaluations continue to show widening inequalities in access to care and persistent inefficiencies in service delivery, this gathering offers a space to address those gaps through data, collaboration, and reform.


The 2026 programme will arrive at a defining moment for the NHS, with digital transformation, workforce strain, and population ageing testing the limits of existing policy frameworks. In this environment, NICE’s leadership on evaluation, innovation, and cost-effectiveness remains essential. The conference will bring together those responsible for translating policy into practice, setting a unified direction for a health and care system that must evolve, or risk falling behind the pace of change.

 
 
 

Recent Posts

See All
Hypermobile Ehlers-Danlos Syndrome

Hypermobile Ehlers-Danlos syndrome, often called hEDS, is a heritable connective tissue disorder in which the body’s structural support system does not behave with ordinary tensile strength.

 
 
 
Hyperandrogenism

Hyperandrogenism is a state of excess androgen effect in women, most often recognized through hirsutism, persistent acne, scalp hair thinning, menstrual irregularity, or infertility.

 
 
 
Hypoandrogenism

Hypoandrogenism refers to a state of reduced androgen effect, whether because the body is producing too little androgen, circulating too little bioavailable hormone, or failing to deliver an adequate

 
 
 

Comments


bottom of page